Yan JL - Search Results

1

A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venous thromboembolism treatment in children with and without cancer.

Hartman LR, Nurmeev I, Svirin P, Wolter KD, Yan JL, Jani D, Goldenberg NA, Sherman N. Hartman LR, et al. Among authors: yan jl. Pediatr Blood Cancer. 2022 Aug;69(8):e29764. doi: 10.1002/pbc.29764. Epub 2022 Jun 9. Pediatr Blood Cancer. 2022. PMID: 35678616 Clinical Trial.

2

Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis.

Martin JM, Macias-Parra M, Mudry P, Conte U, Yan JL, Liu P, Capparella MR, Aram JA. Martin JM, et al. Among authors: yan jl. Pediatr Infect Dis J. 2017 Jan;36(1):e1-e13. doi: 10.1097/INF.0000000000001339. Pediatr Infect Dis J. 2017. PMID: 27636722 Free PMC article. Clinical Trial.

3

A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age.

Roilides E, Carlesse F, Leister-Tebbe H, Conte U, Yan JL, Liu P, Tawadrous M, Aram JA, Queiroz-Telles F; Anidulafungin A8851008 Pediatric Study Group. Roilides E, et al. Among authors: yan jl. Pediatr Infect Dis J. 2019 Mar;38(3):275-279. doi: 10.1097/INF.0000000000002237. Pediatr Infect Dis J. 2019. PMID: 30418357 Clinical Trial.

4

Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.

Purdy J, Jouve S, Yan JL, Balter I, Dartois N, Cooper CA, Korth-Bradley J. Purdy J, et al. Among authors: yan jl. Clin Ther. 2012 Feb;34(2):496-507.e1. doi: 10.1016/j.clinthera.2011.12.010. Epub 2012 Jan 16. Clin Ther. 2012. PMID: 22249106 Clinical Trial.

5

Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis.

Bradley JS, Stone GG, Chan PLS, Raber SR, Riccobene T, Mas Casullo V, Yan JL, Hendrick VM, Hammond J, Leister-Tebbe HK. Bradley JS, et al. Among authors: yan jl. Pediatr Infect Dis J. 2020 May;39(5):411-418. doi: 10.1097/INF.0000000000002607. Pediatr Infect Dis J. 2020. PMID: 32091493 Clinical Trial.

6

Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.

Lee DG, Lee HJ, Yan JL, Lin SS, Aram JA. Lee DG, et al. Among authors: yan jl. Mycoses. 2019 Oct;62(10):969-978. doi: 10.1111/myc.12972. Epub 2019 Aug 18. Mycoses. 2019. PMID: 31355956 Free PMC article. Clinical Trial.

7

Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies.

De Rosa FG, Busca A, Capparella MR, Yan JL, Aram JA. De Rosa FG, et al. Among authors: yan jl. Clin Drug Investig. 2021 Jun;41(6):539-548. doi: 10.1007/s40261-021-01024-7. Epub 2021 Apr 23. Clin Drug Investig. 2021. PMID: 33891293 Free PMC article.

8

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia.

Roilides E, Carlesse F, Tawadrous M, Leister-Tebbe H, Conte U, Raber S, Swanson R, Yan JL, Aram JA, Queiroz-Telles F; Anidulafungin A8851008 Pediatric Study Group. Roilides E, et al. Among authors: yan jl. Pediatr Infect Dis J. 2020 Apr;39(4):305-309. doi: 10.1097/INF.0000000000002568. Pediatr Infect Dis J. 2020. PMID: 32032174 Free PMC article. Clinical Trial.

9

Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial.

Zhuo C, Huang Y, Liu W, Xu JF, Zhu WY, Stone GG, Yan JL, Mohamed N. Zhuo C, et al. Among authors: yan jl. Infect Drug Resist. 2022 Feb 23;15:605-617. doi: 10.2147/IDR.S342558. eCollection 2022. Infect Drug Resist. 2022. PMID: 35237053 Free PMC article.

10

Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.

Hamed K, Engelhardt M, Kovanda LL, Huang JJ, Yan J, Aram JA. Hamed K, et al. Sci Rep. 2023 Apr 25;13(1):6730. doi: 10.1038/s41598-023-31788-1. Sci Rep. 2023. PMID: 37185921 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters